Doctor profile · Federal record
Dr. Madeleine Gantz, MD
Dermatology Physician (CMS: Dermatology) · Houston, TX
- NPI 1821526674
- Accepts Medicare
- MIPS 98.3 / 100 · 2023
- 9 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
Operates at 7 locations .
- Primary practice
-
1900 Saint James Pl Ste 600
Houston, TX 770564136
(713) 850-0240 - Additional location
-
12319 N Mopac Expy Ste 100
Austin, TX 787582486
(512) 837-3376 - Additional location
-
13830 Sawyer Ranch RD Ste 304
Dripping Springs, TX 786205514
(512) 829-0009 - Additional location
-
1601 E Pflugerville Pkwy Ste 1102
Pflugerville, TX 786606148
(512) 252-3700 - Additional location
-
3705 Medical Pkwy Ste 340
Austin, TX 787051023
(512) 454-3781 - Additional location
-
3944 S Fm 620, Bldg 6, Ste 201
Bee Cave, TX 78738
(512) 366-8568 - Additional location
-
5145 Fm 620 N Ste B-110
Austin, TX 787321852
(512) 266-0007 - Mailing address
-
1601 E Pflugerville Pkwy Ste 1102
Pflugerville, TX 786606148
Show 4 more locations
Credentials & registration
- NPI registered
- May 2017 — 9 yrs on file
- Profile last updated
- July 25, 2022
- Year of graduation
- 2017 — 9 yrs since
- Specialty taxonomy
- 207N00000X — NUCC code
- State license (1)
- Texas #T0487
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1821526674. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
330
Distinct HCPCS
10
Medicare allowed
$20,982
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 108 | 24 | $7 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 46 | 45 | $88 | |
17000 |
Destruction of precancer skin growth, 1 growth | 37 | 35 | $54 | |
11102 |
Biopsy of related skin growth, first growth | 31 | 30 | $89 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 24 | 21 | $125 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 22 | 22 | $109 | |
17110 |
Destruction of skin growth, 1-14 growths | 20 | 19 | $113 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 15 | 14 | $57 | |
11103 |
Biopsy of related skin growth, each additional growth | 14 | 12 | $52 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 13 | 13 | $167 |
In context: peer comparison
Among 44 peers in Houston Dermatology Physician, average services per provider: 163. This provider delivers 2.0× the peer median.Open Payments
Industry payments received
All-time total
$841
Transactions
19
Manufacturers
4
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Abbvie INC. | 13 | $477.00 | |
| Galderma Laboratories, L.P. | 4 | $145.46 | |
| Merz North America, INC. | 1 | $138.34 | |
| Sanofi-Aventis U.S. LLC | 1 | $79.99 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
45
Patients
28
Total drug cost
$1,143
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Ketoconazole | Generic | 20 | 16 | $401 |
| Triamcinolone Acetonide | Generic | 13 | 12 | $159 |
| Clobetasol Propionate | Generic | 12 | 0 | $582 |
Frequently asked questions
What is Dr. Madeleine Gantz's medical specialty?
Dr. Madeleine Gantz practices Dermatology Physician in Houston, TX.
Where does Dr. Madeleine Gantz practice?
Dr. Madeleine Gantz practices at 1900 Saint James Pl Ste 600, Houston, TX 770564136. Office phone: 7138500240.
What is Dr. Madeleine Gantz's NPI?
Dr. Madeleine Gantz's National Provider Identifier (NPI) is 1821526674, issued by NPPES.
Does Dr. Madeleine Gantz accept Medicare assignment?
Yes. Dr. Madeleine Gantz accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Madeleine Gantz commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213); Destruction of precancer skin growth, 1 growth (HCPCS 17000). Source: CMS Medicare Physician & Other Practitioners file.